Alternatively, GBM cell-derived iNSCs were utilized to deliver the anti-cancer molecule TRAIL, resulting in a decreased growth of established solid and diffused patient-derived orthotopic xenografts and significantly prolonged median survival of GBM mice [59]. Here, TNFSF10 is linked to glioblastoma.